Dr. Alejandro Berlin completed his MD at Pontificia Universidad Católica de Chile in Santiago, Chile, in 2007 at the top of his class.  He then completed his Radiation Oncology Residency training in Chile and Israel (2007-2011), followed by two years as a faculty Radiation Oncologist in Santiago. In 2013-2014, Dr. Berlin completed a two-year Research Fellowship at the Princess Margaret with a concomitant MSc from the Institute for Medical Sciences (IMS), University of Toronto. 

 

Since September, 2015, Dr. Berlin is as academic clinician-investigator in the Department of Radiation Oncology, University of Toronto at the Princess Margaret Cancer Centre. He's clinically focused in the treatment of central nervous system and genitourinary malignancies with personalized approaches combining systemic, external beam radiation and brachytherapy treatments. He’s interests include innovative clinical trial design, MR-guided brachytherapy for prostate cancer, patient-reported outcomes, and development of novel genomic-based biomarkers. His ongoing studies include pioneering focal MR-guided HDR monotherapy, and novel PSMA PET/MR for guiding ablative stereotactic radiotherapy in early molecularly-define oligometastatic state prostate cancer.

 

Dr. Berlin has been an extremely successful academician throughout his career, having published more than 20 original papers, with a focus on GU oncology and genomics of prostate cancer; many in high-impact cancer journals such as Lancet Oncology, Journal of Clinical Oncology, and Oncotarget.  During his Fellowship year, Dr. Berlin successfully captured 8 competitive awards including the R.S. Bush award for the best fellow at UoT-DRO, scholar of the Flims ECCO-AACR-EORTC-ESMO Workshop, Excellence in Radiation Research for the 21st Century (EIRR21) at CIHR scholarship, The Conquer Cancer Foundation of ASCO Merit Award, Young Scientists ESTRO annual meeting award, and the AACR Travel Award.

 

Dr. Alejandro Berlín